8-K Announcements
6Feb 18, 2026·SEC
Nov 5, 2025·SEC
Aug 6, 2025·SEC
Innospec Inc. (IOSP) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Innospec Inc. (IOSP) stock price & volume — 10-year historical chart
Innospec Inc. (IOSP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Innospec Inc. (IOSP) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 17, 2026 | $1.50vs $1.26+19.0% | $456Mvs $461M-1.1% |
| Q4 2025 | Nov 4, 2025 | $1.12vs $1.03+8.7% | $442Mvs $461M-4.1% |
| Q3 2025 | Aug 5, 2025 | $1.26vs $1.17+7.7% | $440Mvs $450M-2.3% |
| Q2 2025 | May 8, 2025 | $1.42vs $1.40+1.4% | $441Mvs $468M-5.7% |
Innospec Inc. (IOSP) competitors in Specialty additives and formulation chemicals — business model, growth, and fundamentals comparison
Innospec Inc. (IOSP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Innospec Inc. (IOSP) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.31B | 1.48B | 1.51B | 1.19B | 1.48B | 1.96B | 1.95B | 1.85B | 1.78B |
| Revenue Growth % | 47.93% | 13.02% | 2.46% | -21.16% | 24.33% | 32.38% | -0.76% | -5.31% | -3.65% |
| Cost of Goods Sold | 903.5M | 1.04B | 1.05B | 850.4M | 1.05B | 1.38B | 1.36B | 1.3B | 1.29B |
| COGS % of Revenue | 69.14% | 70.55% | 69.19% | 71.28% | 70.68% | 70.12% | 69.67% | 70.58% | 72.31% |
| Gross Profit | 403.3M▲ 0% | 435M▲ 7.9% | 466.2M▲ 7.2% | 342.7M▼ 26.5% | 434.9M▲ 26.9% | 586.7M▲ 34.9% | 591.1M▲ 0.7% | 542.9M▼ 8.2% | 492.4M▼ 9.3% |
| Gross Margin % | 30.86% | 29.45% | 30.81% | 28.72% | 29.32% | 29.88% | 30.33% | 29.42% | 27.69% |
| Gross Profit Growth % | 21.37% | 7.86% | 7.17% | -26.49% | 26.9% | 34.9% | 0.75% | -8.15% | -9.3% |
| Operating Expenses | 270.9M | 294.4M | 316.3M | 309M | 302.8M | 399.4M | 429.5M | 365M | 336.1M |
| OpEx % of Revenue | 20.73% | 19.93% | 20.9% | 25.9% | 20.41% | 20.34% | 22.04% | 19.78% | 18.9% |
| Selling, General & Admin | 239.5M | 261M | 280.9M | 237M | 267.2M | 360.7M | 387.8M | 314M | 285.1M |
| SG&A % of Revenue | 18.33% | 17.67% | 18.56% | 19.86% | 18.01% | 18.37% | 19.9% | 17.02% | 16.03% |
| Research & Development | 31.4M | 33.4M | 35.4M | 30.9M | 37.4M | 38.7M | 41.7M | 47.8M | 51M |
| R&D % of Revenue | 2.4% | 2.26% | 2.34% | 2.59% | 2.52% | 1.97% | 2.14% | 2.59% | 2.87% |
| Other Operating Expenses | 0 | 0 | 0 | 41.1M | -1.8M | 0 | 0 | 3.2M | 0 |
| Operating Income | 129.7M▲ 0% | 133.5M▲ 2.9% | 149.9M▲ 12.3% | 33.7M▼ 77.5% | 132.1M▲ 292.0% | 187.3M▲ 41.8% | 161.6M▼ 13.7% | 177.9M▲ 10.1% | 156.3M▼ 12.1% |
| Operating Margin % | 9.93% | 9.04% | 9.91% | 2.82% | 8.91% | 9.54% | 8.29% | 9.64% | 8.79% |
| Operating Income Growth % | 23.05% | 2.93% | 12.28% | -77.52% | 291.99% | 41.79% | -13.72% | 10.09% | -12.14% |
| EBITDA | 185.3M | 189.2M | 200.9M | 79.7M | 174.8M | 227.4M | 200.9M | 221.4M | 205.6M |
| EBITDA Margin % | 14.18% | 12.81% | 13.28% | 6.68% | 11.78% | 11.58% | 10.31% | 12% | 11.56% |
| EBITDA Growth % | 29.49% | 2.1% | 6.18% | -60.33% | 119.32% | 30.09% | -11.65% | 10.2% | -7.14% |
| D&A (Non-Cash Add-back) | 55.6M | 55.7M | 51M | 46M | 42.7M | 40.1M | 39.3M | 43.5M | 49.3M |
| EBIT | 136.3M | 138.5M | 155.2M | 41.5M | 130.3M | 187.3M | 161.6M | 181.1M | 156.3M |
| Net Interest Income | -8.2M | -6.9M | -4.8M | -1.8M | -1.5M | -1.1M | 0 | 0 | 9.2M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.2M |
| Interest Expense | 8.2M | 6.9M | 4.8M | 1.8M | 1.5M | 1.1M | 0 | 0 | 0 |
| Other Income/Expense | -4.3M | -1.9M | 500K | 6M | 2.3M | -2.7M | 12.8M | -136.7M | -18.2M |
| Pretax Income | 128.1M▲ 0% | 131.6M▲ 2.7% | 150.4M▲ 14.3% | 39.7M▼ 73.6% | 134.4M▲ 238.5% | 184.6M▲ 37.4% | 174.4M▼ 5.5% | 41.2M▼ 76.4% | 138.1M▲ 235.2% |
| Pretax Margin % | 9.8% | 8.91% | 9.94% | 3.33% | 9.06% | 9.4% | 8.95% | 2.23% | 7.77% |
| Income Tax | 66.3M | 46.6M | 38.2M | 11M | 41.3M | 51.6M | 35.3M | 5.6M | 21.5M |
| Effective Tax Rate % | 51.76% | 35.41% | 25.4% | 27.71% | 30.73% | 27.95% | 20.24% | 13.59% | 15.57% |
| Net Income | 61.8M▲ 0% | 85M▲ 37.5% | 112.2M▲ 32.0% | 28.7M▼ 74.4% | 93.1M▲ 224.4% | 133M▲ 42.9% | 139.1M▲ 4.6% | 35.6M▼ 74.4% | 116.6M▲ 227.5% |
| Net Margin % | 4.73% | 5.76% | 7.41% | 2.41% | 6.28% | 6.77% | 7.14% | 1.93% | 6.56% |
| Net Income Growth % | -23.99% | 37.54% | 32% | -74.42% | 224.39% | 42.86% | 4.59% | -74.41% | 227.53% |
| Net Income (Continuing) | 61.8M | 85M | 112.2M | 28.7M | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 400K | 500K | 400K | 500K | 600K | 2.4M | 2.5M | 4.9M | 6.8M |
| EPS (Diluted) | 2.52▲ 0% | 3.45▲ 36.9% | 4.54▲ 31.6% | 1.16▼ 74.4% | 3.75▲ 223.3% | 5.32▲ 41.9% | 5.56▲ 4.5% | 1.42▼ 74.5% | 4.67▲ 228.9% |
| EPS Growth % | -24.32% | 36.9% | 31.59% | -74.45% | 223.28% | 41.87% | 4.51% | -74.46% | 228.87% |
| EPS (Basic) | 2.56 | 3.48 | 4.58 | 1.17 | 3.78 | 5.37 | 5.60 | 1.43 | 4.69 |
| Diluted Shares Outstanding | 24.49M | 24.6M | 24.73M | 24.78M | 24.85M | 24.98M | 25.02M | 25.12M | 24.99M |
| Basic Shares Outstanding | 24.15M | 24.4M | 24.48M | 24.56M | 24.65M | 24.79M | 24.85M | 24.93M | 24.88M |
| Dividend Payout Ratio | 30.1% | 25.53% | 22.28% | 89.2% | 30.93% | 23.83% | 25.23% | 108.99% | 36.36% |
Innospec Inc. (IOSP) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 561.5M | 663.9M | 630.3M | 566.2M | 728.1M | 872.6M | 885.7M | 956.6M | 1B |
| Cash & Short-Term Investments | 90.2M | 123.1M | 75.7M | 105.3M | 141.8M | 147.1M | 203.7M | 289.2M | 292.5M |
| Cash Only | 90.2M | 123.1M | 75.7M | 105.3M | 141.8M | 147.1M | 203.7M | 289.2M | 292.5M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 244.5M | 279.7M | 292M | 221.4M | 284.5M | 334.6M | 359.8M | 341.7M | 342.3M |
| Days Sales Outstanding | 68.29 | 69.12 | 70.43 | 67.73 | 70 | 62.19 | 67.39 | 67.58 | 70.27 |
| Inventory | 209.8M | 248M | 244.6M | 220M | 277.6M | 373.1M | 300.1M | 301M | 329.3M |
| Days Inventory Outstanding | 84.76 | 86.88 | 85.26 | 94.43 | 96.64 | 98.9 | 80.68 | 84.35 | 93.49 |
| Other Current Assets | 1.1M | 0 | 800K | 400K | 400K | 400K | 600K | 600K | 40.5M |
| Total Non-Current Assets | 848.7M | 809.5M | 838.5M | 831.2M | 842.8M | 731.1M | 821.7M | 778.1M | 827.8M |
| Property, Plant & Equipment | 196M | 196.4M | 231.1M | 250.9M | 249.8M | 266.2M | 313.4M | 314.5M | 338.8M |
| Fixed Asset Turnover | 6.67x | 7.52x | 6.55x | 4.76x | 5.94x | 7.38x | 6.22x | 5.87x | 5.25x |
| Goodwill | 361.8M | 364.9M | 363M | 371.2M | 364.3M | 358.8M | 399.3M | 382.5M | 399M |
| Intangible Assets | 163.3M | 136.3M | 113.5M | 75.3M | 57.5M | 45M | 57.3M | 65.4M | 67.7M |
| Long-Term Investments | 116M | 95.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5.1M | 7.2M | 121.8M | 126.2M | 164.8M | 55.2M | 41.3M | 6.3M | 8.7M |
| Total Assets | 1.41B▲ 0% | 1.47B▲ 4.5% | 1.47B▼ 0.3% | 1.4B▼ 4.9% | 1.57B▲ 12.4% | 1.6B▲ 2.1% | 1.71B▲ 6.5% | 1.73B▲ 1.6% | 1.83B▲ 5.6% |
| Asset Turnover | 0.93x | 1.00x | 1.03x | 0.85x | 0.94x | 1.22x | 1.14x | 1.06x | 0.97x |
| Asset Growth % | 19.37% | 4.48% | -0.31% | -4.86% | 12.42% | 2.09% | 6.47% | 1.6% | 5.63% |
| Total Current Liabilities | 261.6M | 296.6M | 303.5M | 252.4M | 336.6M | 405.8M | 371.5M | 371.4M | 360.1M |
| Accounts Payable | 117.9M | 126.8M | 122M | 98.7M | 148.7M | 165.3M | 163.6M | 163.8M | 174.7M |
| Days Payables Outstanding | 47.63 | 44.42 | 42.53 | 42.36 | 51.76 | 43.82 | 43.98 | 45.9 | 49.6 |
| Short-Term Debt | 15.8M | 21.4M | 0 | 0 | 0 | 0 | 0 | 0 | 15.9M |
| Deferred Revenue (Current) | 100K | 8.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.1M | 5.9M | 5.6M | 6.6M | 5.2M | 5.3M | 5.8M | 5M | 164.2M |
| Current Ratio | 2.15x | 2.24x | 2.08x | 2.24x | 2.16x | 2.15x | 2.38x | 2.58x | 2.79x |
| Quick Ratio | 1.34x | 1.40x | 1.27x | 1.37x | 1.34x | 1.23x | 1.58x | 1.77x | 1.88x |
| Cash Conversion Cycle | 105.42 | 111.58 | 113.17 | 119.8 | 114.88 | 117.27 | 104.08 | 106.03 | 114.16 |
| Total Non-Current Liabilities | 354.3M | 351.3M | 246.4M | 200.1M | 201.3M | 157.5M | 186.3M | 147.2M | 55.9M |
| Long-Term Debt | 202.6M | 186.2M | 58.6M | 0 | 0 | 0 | 0 | 0 | 36.8M |
| Capital Lease Obligations | 3.2M | 1.5M | 22.4M | 29M | 23.1M | 31.4M | 31.6M | 31M | 36.8M |
| Deferred Tax Liabilities | 45M | 48.2M | 49.6M | 46.9M | 60.8M | 26.2M | 33.5M | 23.5M | 19.1M |
| Other Non-Current Liabilities | 103.1M | 115.4M | 115.8M | 124.2M | 117.4M | 99.9M | 121.2M | 92.7M | -36.8M |
| Total Liabilities | 615.9M | 647.9M | 549.9M | 452.5M | 537.9M | 563.3M | 557.8M | 518.6M | 416M |
| Total Debt | 224.3M | 210.9M | 92.6M | 40.8M | 35.6M | 45.3M | 45.2M | 44.9M | 89.5M |
| Net Debt | 134.1M | 87.8M | 16.9M | -64.5M | -106.2M | -101.8M | -158.5M | -244.3M | -203M |
| Debt / Equity | 0.28x | 0.26x | 0.10x | 0.04x | 0.03x | 0.04x | 0.04x | 0.04x | 0.06x |
| Debt / EBITDA | 1.21x | 1.11x | 0.46x | 0.51x | 0.20x | 0.20x | 0.22x | 0.20x | 0.44x |
| Net Debt / EBITDA | 0.72x | 0.46x | 0.08x | -0.81x | -0.61x | -0.45x | -0.79x | -1.10x | -0.99x |
| Interest Coverage | 15.82x | 19.35x | 31.23x | 18.72x | 88.07x | 170.27x | - | - | - |
| Total Equity | 794.7M▲ 0% | 826M▲ 3.9% | 918.9M▲ 11.2% | 944.9M▲ 2.8% | 1.03B▲ 9.3% | 1.04B▲ 0.7% | 1.15B▲ 10.5% | 1.22B▲ 5.8% | 1.42B▲ 16.5% |
| Equity Growth % | 21.5% | 3.94% | 11.25% | 2.83% | 9.32% | 0.72% | 10.5% | 5.78% | 16.47% |
| Book Value per Share | 32.46 | 33.57 | 37.16 | 38.13 | 41.56 | 41.65 | 45.94 | 48.41 | 56.67 |
| Total Shareholders' Equity | 794.3M | 825.5M | 918.5M | 944.4M | 1.03B | 1.04B | 1.15B | 1.21B | 1.33B |
| Common Stock | 300K | 300K | 300K | 300K | 300K | 300K | 300K | 300K | 300K |
| Retained Earnings | 605M | 668.3M | 755.5M | 758.6M | 822.9M | 924.2M | 1.03B | 1.02B | 1.1B |
| Treasury Stock | -93.3M | -92.8M | -93.3M | -93.3M | -90.6M | -95.4M | -94.3M | -93M | -115.2M |
| Accumulated OCI | -38.5M | -75.7M | -74.4M | -57.3M | -46.9M | -145.2M | -148.1M | -91M | -34.7M |
| Minority Interest | 400K | 500K | 400K | 500K | 600K | 2.4M | 2.5M | 4.9M | 6.8M |
Innospec Inc. (IOSP) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 82.7M | 104.9M | 161.6M | 145.9M | 93.2M | 81.7M | 207.3M | 184.5M | 138.3M |
| Operating CF Margin % | 6.33% | 7.1% | 10.68% | 12.23% | 6.28% | 4.16% | 10.64% | 10% | 7.78% |
| Operating CF Growth % | -20.86% | 26.84% | 54.05% | -9.72% | -36.12% | -12.34% | 153.73% | -11% | -25.04% |
| Net Income | 61.8M | 85M | 112.2M | 28.7M | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Depreciation & Amortization | 50.4M | 49.6M | 47.6M | 46M | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M |
| Stock-Based Compensation | 4.1M | 4.9M | 26.7M | 5.8M | 4.4M | 6.7M | 8M | 8.5M | 8.1M |
| Deferred Taxes | -6.7M | 5.5M | 0 | -2.5M | 6.4M | -5.5M | 3.6M | -39.3M | -10.2M |
| Other Non-Cash Items | -1.9M | -5.3M | -4.1M | 17.8M | -5.3M | -2.5M | -3.3M | 155.1M | -19.8M |
| Working Capital Changes | -25M | -34.8M | -20.8M | 50.1M | -48.1M | -90.1M | 20.6M | -18.9M | 0 |
| Change in Receivables | -83.2M | -45.7M | -18.2M | 10.1M | -31.4M | -55.5M | -12.6M | 4.3M | 0 |
| Change in Inventory | -30.8M | -42.2M | 2.4M | 25.5M | -62M | -98.5M | 83M | -11.8M | 0 |
| Change in Payables | 48.6M | 38.4M | 0 | -45.9M | 90.2M | 54.2M | -26.9M | -4.5M | 0 |
| Cash from Investing | -29.6M | -35.5M | -31M | -29.7M | -36.2M | -42.1M | -111.8M | -62M | -75.1M |
| Capital Expenditures | -32.2M | -30.1M | -29.9M | -29.7M | -39.1M | -42.3M | -77.2M | -62.3M | -50.3M |
| CapEx % of Revenue | 2.46% | 2.04% | 1.98% | 2.49% | 2.64% | 2.15% | 3.96% | 3.38% | 2.83% |
| Acquisitions | 2.6M | -5.4M | 0 | 100K | 3M | 2M | -34.7M | -200K | -700K |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -8.9M | -1.2M | -1.1M | -100K | -100K | -1.8M | 100K | 500K | -24.1M |
| Cash from Financing | -66.4M | -36.2M | -177.9M | -86.8M | -20M | -33.7M | -39M | -35.3M | -63.9M |
| Debt Issued (Net) | -53.5M | -14.2M | -150.2M | -61.1M | -600K | -100K | -2.3M | 0 | 0 |
| Equity Issued (Net) | 1000K | -300K | -1000K | 100K | 1000K | -1000K | -200K | 1000K | 0 |
| Dividends Paid | -18.6M | -21.7M | -25M | -25.6M | -28.8M | -31.7M | -35.1M | -38.8M | -42.4M |
| Share Repurchases | -1.1M | -1.4M | -2.4M | -2.1M | -800K | -5.9M | -1.1M | -700K | 0 |
| Other Financing | 0 | 0 | -300K | -200K | 100K | 1.8M | -1.4M | 2.1M | -21.5M |
| Net Change in Cash | -11.7M▲ 0% | 32.9M▲ 381.2% | -47.4M▼ 244.1% | 29.6M▲ 162.4% | 36.5M▲ 23.3% | 5.3M▼ 85.5% | 56.6M▲ 967.9% | 85.5M▲ 51.1% | 3.3M▼ 96.1% |
| Free Cash Flow | 50.5M▲ 0% | 74.8M▲ 48.1% | 131.7M▲ 76.1% | 116.2M▼ 11.8% | 54.1M▼ 53.4% | 39.4M▼ 27.2% | 145.2M▲ 268.5% | 143.1M▼ 1.4% | 88M▼ 38.5% |
| FCF Margin % | 3.86% | 5.06% | 8.7% | 9.74% | 3.65% | 2.01% | 7.45% | 7.75% | 4.95% |
| FCF Growth % | -42.61% | 48.12% | 76.07% | -11.77% | -53.44% | -27.17% | 268.53% | -1.45% | -38.5% |
| FCF per Share | 2.06 | 3.04 | 5.33 | 4.69 | 2.18 | 1.58 | 5.80 | 5.70 | 3.52 |
| FCF Conversion (FCF/Net Income) | 1.34x | 1.23x | 1.44x | 5.08x | 1.00x | 0.61x | 1.49x | 5.18x | 1.19x |
| Interest Paid | 0 | 0 | 4.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Innospec Inc. (IOSP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 12.91% | 8.53% | 10.49% | 12.86% | 3.08% | 9.41% | 12.83% | 12.7% | 3.01% | 8.86% |
| Return on Invested Capital (ROIC) | 11.05% | 11.09% | 10.87% | 12.16% | 2.78% | 10.96% | 15.06% | 12.56% | 13.59% | 10.73% |
| Gross Margin | 37.62% | 30.86% | 29.45% | 30.81% | 28.72% | 29.32% | 29.88% | 30.33% | 29.42% | 27.69% |
| Net Margin | 9.2% | 4.73% | 5.76% | 7.41% | 2.41% | 6.28% | 6.77% | 7.14% | 1.93% | 6.56% |
| Debt / Equity | 0.42x | 0.28x | 0.26x | 0.10x | 0.04x | 0.03x | 0.04x | 0.04x | 0.04x | 0.06x |
| Interest Coverage | 32.94x | 15.82x | 19.35x | 31.23x | 18.72x | 88.07x | 170.27x | - | - | - |
| FCF Conversion | 1.29x | 1.34x | 1.23x | 1.44x | 5.08x | 1.00x | 0.61x | 1.49x | 5.18x | 1.19x |
| Revenue Growth | -12.73% | 47.93% | 13.02% | 2.46% | -21.16% | 24.33% | 32.38% | -0.76% | -5.31% | -3.65% |
Innospec Inc. (IOSP) SEC filings — annual & quarterly reports (10-K, 10-Q)
Feb 18, 2026·SEC
Nov 5, 2025·SEC
Aug 6, 2025·SEC
Innospec Inc. (IOSP) stock FAQ — growth, dividends, profitability & financials explained
Innospec Inc. (IOSP) reported $1.78B in revenue for fiscal year 2025. This represents a 282% increase from $465.0M in 1998.
Innospec Inc. (IOSP) saw revenue decline by 3.7% over the past year.
Yes, Innospec Inc. (IOSP) is profitable, generating $116.6M in net income for fiscal year 2025 (6.6% net margin).
Yes, Innospec Inc. (IOSP) pays a dividend with a yield of 2.18%. This makes it attractive for income-focused investors.
Innospec Inc. (IOSP) has a return on equity (ROE) of 8.9%. This is below average, suggesting room for improvement.
Innospec Inc. (IOSP) generated $88.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Innospec Inc. (IOSP) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates